LEADER 01777nam  2200421 a 450 
001 9910701958903321
005 20120716145736.0
035   $a(CKB)5470000002422528
035   $a(OCoLC)799892743
035   $a(EXLCZ)995470000002422528
100   $a20120716d1978      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aBioassay of beta-2'-deoxy-6-thioguanosine monohydrate for possible carcinogenicity$b[electronic resource] /$fCarcinogenesis Testing Program, Division of Cancer Cause and Prevention, National Cancer Institute, National Institutes of Health
210  1$aBethesda, Md. :$cU.S. Dept. of Health, Education and Welfare, Public Health Service, National Institutes of Health,$d1978.
215   $a1 online resource (xiv, 122 pages) $cillustrations
225 1 $aDHEW publication ;$vno. (NIH) 78-1363
225 1 $aCarcinogenesis technical report series ;$vno. 57
300   $aTitle from title screen (viewed on July 16, 2012).
300   $aCAS no. 789-61-7.
300   $a"NCI-CG-TR-57."
517 3 $aBioassay of [beta]-TGdR for possible carcinogenicity
606   $aCarcinogenicity testing
606   $aAntineoplastic agents$xToxicology
615  0$aCarcinogenicity testing.
615  0$aAntineoplastic agents$xToxicology.
712 02$aCarcinogenesis Testing Program (U.S.)
712 02$aNational Cancer Institute (U.S.).$bDivision of Cancer Cause and Prevention.
712 02$aNational Institutes of Health (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910701958903321
996   $aBioassay of beta-2'-deoxy-6-thioguanosine monohydrate for possible carcinogenicity$93114840
997   $aUNINA